JeanMarie Guenot and Her Contribution to the Pharmaceutical Industry

JeanMarie Guenot is a very successful and accomplished business lady and is a female role model. She has worked for over 20 years in the pharmaceutical and biotechnology industry. Jeanmarie Guenot is the President and CEO of Amphivena Therapeutics, a company which is developing breakthrough bi-functional antibody medicine for hematologic malignancies. Guenot has worked at all levels in large enterprises in the pharmaceutical, business development, commercial and corporate development, project and alliance management and venture capital.

Early Career

JeanMarie Guenot began her glittering entrepreneurial career at the Atlas Venture where she started life science firms and managed venture capital investments. She worked as a scientist in Preclinical R&D at the Hoffman-La Roche. While working at the Hoffman-La Roche, she discovered and developed drugs for metabolic diseases, autoimmune diseases, oncology, and inflammation. She has studied physical and medicinal chemistry. Dr. Guenot has specialized in X-Ray NMR refinement, semi-empirical methods in molecular dynamics, quantum mechanical systems, and protein structure prediction on guenotllc.com. She got her Master of Business Administration degree at the University of Pennsylvania. After that, she did her Ph.D. at the University of California.

Work History

According to Crunchbase, Guenot founded SKS Ocular before starting to work for Amphivena Therapeutics. SKS was a pharmaceutical company which focused on the development of new therapeutics for significant unmet medical needs. It specialized on dry AMD, molecular degeneration, constant release of ocular drug delivery technologies, therapeutics for glaucoma and ocular inflammation therapeutics.

At Hoffman-La Roche in Shanghai and Basel, Guenot was a business advisor on amphivena.com. She was also the Vice President of Corporate together with Business Development at the PDL BioPharma. When she was working for BioPharma, she led licensing, alliance management, mergers and acquisitions and commercial portfolios. JeanMarie was also involved in the Biogen Idec-PDL development and collaboration for commercialization. This included three Phase-2 cancer together with autoimmune disease drug patients. It was a $800million transaction that included a $100 million equity investment n PDL as well as therapeutic candidates.

Guenot holds portfolio projects and alliance management expertise in various sectors such as cardiovascular diseases, ophthalmic diseases, oncology, neurology and autoimmune diseases. She licensed the well-known ophthalmic indication for oncology drug to Ophthotech.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

Amazing Information about the Scoutahead.com Founder Raj Fernando

Raj Fernando is the Founder, Chairman, and the CEO of Scoutahead.com. He is the former founder and the CEO of the Chopper Trading. Mr. Fernando uses his over 25 years experience in the global financial markets to give advisory services to his companies and boards that he serves. He also has over ten years experience with the cyber securities initiatives. Mr. Fernando graduated from Beloit College with an economics and history degree, and then attended the University of London. He started Scoutahead.com in 2016. Since inception, the company has been providing trusted information to their clients with the aim of increasing their productivity and aiding in their growth.

Mr. Fernando began his career while still in college. He volunteered with the Chicago Mercantile Exchange, and he continued working with them after completing his college degree. Raj Fernando served in various departments at the Chicago Board of Trade in 1991 to 2001, working his way up from the lowest positions to the executive positions. He worked with other trading firms including Rosenthal Collins Group, LFG, and Indosuez Carr Futures. Later, he started Chopper Trading in 2002, and he stopped full-time trading to concentrate on building his company.

Chopper Trading is a trading company headquartered at Chicago Board of Trade Building. The company has approximately 250 employees who are the brightest engineers and traders. He hires the very best in the industry. Raj Fernando is selective on the workforce that he wants and therefore, his workers go through a lengthy and involving training program and choose the best employees who are interested in a long-term engagement with the company. Through his leadership, the company has risen into one of the largest markets globally. Chopper Trading has in the past traded on the CME, Nasdaq, Eurex, ICE, and LSE. Mr. Fernando sold the company to DRW in 2015.

Additionally, Raj Fernando is on the Board of Directors for PAWS Chicago, American Security Project, and Chicago Council on Global Affairs. Mr. Fernando is a member of the Board of Trustees of the Chicago Symphony Orchestra, and he is on the Foreign Leadership Committee member at the Brookings Institute.

visit facebook page : www.facebook.com/rajivfernano